Antigenic and virological characteristics of SARS-CoV-2 variants BA.3.2, XFG, and NB.1.8.1
- PMID: 40484018
- DOI: 10.1016/S1473-3099(25)00308-1
Antigenic and virological characteristics of SARS-CoV-2 variants BA.3.2, XFG, and NB.1.8.1
Conflict of interest statement
CG and YY contributed equally. YC has provisional patent applications for the BD series antibodies (WO2024131775A9 and WO2023151312A1), and is the founder of Singlomics Biopharmaceuticals. All other authors declare no competing interests.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous